NCT03598595 2026-02-04Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory OsteosarcomaM.D. Anderson Cancer CenterPhase 1/2 Active not recruiting31 enrolled
NCT04185883 2025-10-22Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)AmgenPhase 1 Active not recruiting610 enrolled